Non-systemic delivery of topical brimonidine to the brain: A neuro-ocular tissue distribution study

Author： Tamilvanan Shunmugaperumal Abdulrazik Muhammad Benita Simon

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.14, Iss.10, 2006-12, pp. : 670-679

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical Brimonidine 0.2%/Timolol 0.5% Ophthalmic Solution: In Glaucoma and Ocular Hypertension

By Frampton James E.

Drugs & Aging, Vol. 23, Iss. 9, 2006-01 ,pp. : 753-761

Adis International

Access to resources Recommend Favorite

Non-Systemic Drugs: A Critical Review

Current Pharmaceutical Design, Vol. 18, Iss. 10, 2012-04 ,pp. : 1434-1445

Bentham Science Publishers

Access to resources Recommend Favorite

Brimonidine Imprinted Hydrogels and Evaluation of Their Binding and Releasing Properties as New Ocular Drug Delivery Systems

Current Drug Delivery, Vol. 12, Iss. 6, 2015-12 ,pp. : 717-725

Bentham Science Publishers

Access to resources Recommend Favorite

Sustained Ocular Delivery of Brimonidine Tartrate Using Ion Activated In Situ Gelling System

Current Drug Delivery, Vol. 9, Iss. 2, 2012-03 ,pp. : 197-204

Bentham Science Publishers

Access to resources Recommend Favorite

Colesevelam HCl: a non-systemic lipidaltering drug

By Bays Harold Dujovne Carlos

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 779-790

Informa Healthcare

Access to resources Recommend Favorite